350 Hills Street
United States - Map
IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is based in Richland, Washington.
|Mr. Dwight Babcock ,
Chairman and Chief Exec. Officer
|Mr. Fredric Swindler ,
VP of Regulatory & Quality Affairs and Corp. Sec.
|Mr. Robert Bilella ,
Ne Area Sales Director
|Mr. William Cavanagh III,
VP of R&D and VP of R&D for Isoray Medical Inc
|Mr. Brien L. Ragle ,
Principal Financial & Accounting Officer and Controller
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|